ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 620077 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 620077; 2) Community: the network communities that were significantly associated with the response to NSC 620077; 3) Molecule: the relationships between components within communities and NSC 620077; 4) MDR: the compounds that were significantly associated with the NSC 620077.

NSC Compound Enrichment Correlation
NSC 303861 L-Cysteine analog 0.0490935610249067 0.35056001
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0490935610249067 0.34569726
NSC 328410 Camptothecin Derivative 0.0490935610249067 0.15076206
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0490935610249067 0.32487251
NSC 34757 Melicopidine 0.0490935610249067 0.35012664
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0490935610249067 0.32065858
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0490935610249067 0.094412641
NSC 355457 11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride 0.0490935610249067 0.20097568
NSC 371777 Null 0.0490935610249067 0.00660502
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0490935610249067 0.28728639
Total:108  Current:102    [First] [Prev] [Next] [Last]